Literature DB >> 19073221

Elevated forebrain excitatory L-glutamate, L-aspartate and D-aspartate in the Naples high-excitability rats.

L A Ruocco1, U A Gironi Carnevale, A G Sadile, A Sica, C Arra, A Di Maio, E Topo, A D'Aniello.   

Abstract

The Naples high-excitability (NHE) rats are thought to model the mesocortical variant of attention-deficit hyperactivity disorder (ADHD). The aim of this study was to investigate forebrain level of L-glutamate, L-aspartate and D-aspartate, in NHE vs. Naples random bred (NRB) control rats. Thus, prepuberal NHE and NRB rats were daily handled in the 5th and 6th week of postnatal life. Then rats were exposed to two spatial novelties i.e. a Làt and a Olton maze for 10 min. Amino acids were detected by HPLC in the prefrontal cortex (PFC), striatum (STR), hippocampus (HPC) and hypothalamus (HYP). Results indicate that all amino acids were higher in NHE than in NRB rats. This, in turn, may explain the behavioural hyperactivity and attention deficit of this animal model of ADHD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19073221     DOI: 10.1016/j.bbr.2008.11.029

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  2 in total

Review 1.  A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders.

Authors:  Marco A Grados; Elizabeth B Atkins; Gabriela I Kovacikova; Erin McVicar
Journal:  Psychol Res Behav Manag       Date:  2015-04-28

2.  Prepuberal stimulation of 5-HT7-R by LP-211 in a rat model of hyper-activity and attention-deficit: permanent effects on attention, brain amino acids and synaptic markers in the fronto-striatal interface.

Authors:  Lucia A Ruocco; Concetta Treno; Ugo A Gironi Carnevale; Claudio Arra; Gianpiero Boatto; Maria Nieddu; Cristina Pagano; Placido Illiano; Fabiana Barbato; Angela Tino; Ezio Carboni; Giovanni Laviola; Enza Lacivita; Marcello Leopoldo; Walter Adriani; Adolfo G Sadile
Journal:  PLoS One       Date:  2014-04-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.